特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
770579

世界の液体生検市場調査と予測

Global Liquid Biopsy Market Research and Forecast, 2018-2023

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
世界の液体生検市場調査と予測
出版日: 2018年12月28日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の液体生検市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 レポートのサマリー

第2章 市場概要と洞察

  • 市場の定義
  • バリューチェーン
  • アナリストの見解と現在の市場動向
  • 法規制

第3章 市場決定因子

  • 促進因子
  • 阻害因子
  • 機会

第4章 市場セグメンテーション

  • バイオマーカータイプ別市場
    • 循環腫瘍細胞
    • 循環腫瘍DNA
    • その他
  • 癌タイプ別市場
    • 肺癌
    • 乳癌
    • 前立腺癌
    • 大腸癌
    • その他
  • エンドユーザー別市場
    • 病院、試験所
    • 学術研究機関

第5章 競合環境

  • 主要企業分析
  • 主要戦略分析

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の諸国

第7章 企業プロファイル

  • Biocept Inc.
  • Biodesix, Inc.
  • Bio-Rad Laboratories Inc.
  • CellMax Life
  • Circulogene
  • Clearbridge Biomedics Pte Ltd.
  • Cynvenio Biosystems, Inc.
  • Epigenomics AG
  • Exosome Diagnostics Inc.
  • F. Hoffmann-La Roche AG
  • Genomic Health Inc.
  • Guardant Health Inc.
  • Inivata Ltd.
  • Lariat Biosciences, Inc.
  • MDxHealth SA
  • Menarini-Silicon Biosystems
  • Personal Genome Diagnostics Inc.
  • QIAGEN NV
  • Raindance Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Trovagene, Inc.
図表

List of Tables

  • TABLE # 1 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL CIRCULATING TUMOR CELLS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL CIRCULATING TUMOR DNA MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL COLORECTAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL OTHER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 12 GLOBAL HOSPITALS AND LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 13 GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 14 GLOBAL LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 15 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 16 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 17 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 18 NORTH AMERICA LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 19 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 20 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 21 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 22 EUROPE LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 23 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 24 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 25 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 26 ASIA-PACIFIC LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 27 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 28 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY CANCER TYPE, 2017-2023 ($ MILLION)
  • TABLE # 29 REST OF THE WORLD LIQUID BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL LIQUID BIOPSY MARKET SHARE BY BIOMARKER TYPE, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL LIQUID BIOPSY MARKET SHARE BY CANCER TYPE, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL LIQUID BIOPSY MARKET SHARE BY END-USER, 2017 VS 2023 (%)
  • FIGURE # 4 GLOBAL LIQUID BIOPSY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 5 US LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 UK LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 FRANCE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 GERMANY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 ITALY LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 SPAIN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 ROE LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 INDIA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 CHINA LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 JAPAN LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 REST OF THE WORLD LIQUID BIOPSY MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018468

Global liquid biopsy market is projected to witness a steady growth during the forecasted period 2018-2023. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market. however, lack of awareness in developing and underdeveloped countries hamper the growth of the market. Moreover, technological advancement in a liquid biopsy with growing investment and funding for R&D create a future opportunity for the growth of the market during the forecast period.

Global liquid biopsy market is segmented on the basis of biomarker type, cancer type, and end-user. According to the biomarker type, the market is further sub-segmented as circulating tumor cells, circulating tumor DNA and others such as extracellular vesicles. According to the cancer type, the market is further diversified as lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. Moreover, according to the end-user, the market is further diversified as hospitals and laboratories, and academic and research institutes.

Global liquid biopsy market can be geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. High prevalence of cancer diseases and the investment in R&D in the US has boosted the growth of the market in North America. The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecasted period. The growth in the Asia-Pacific market is backed by the growing awareness about the diagnosis and treatment for cancer diseases within the countries. Along with it, efforts by the government funding on research programs is aiding in the growth of the Asia-Pacific liquid biopsy market.

The key players of the global liquid biopsy market include Biocept Inc., Bio-Rad Laboratories Inc., Biodesix Inc., Hoffmann-La Roche Ltd., and others. The players have adopted inorganic growth strategies for enhancing their overall revenue. With these strategies, the players aimed at advancing innovation and investing significantly in medical needs.

Research Methodology

The market study of liquid biopsy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

Financial reports of companies involved in the market

Whitepapers, research-papers and news blogs

Company websites and their product catalog.

The report is intended for hospitals, laboratories, diagnostic centers, and government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

Global Liquid Biopsy Market Research and Analysis by Biomarker Type

Global Liquid Biopsy Market Research and Analysis by Cancer Type

Global Liquid Biopsy Market Research and Analysis by End-User

Global Liquid Biopsy Market Research and Analysis by Region

The Report Covers:

Comprehensive research methodology of global liquid biopsy market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global liquid biopsy market.

Insights about market determinants which are stimulating the global liquid biopsy market.

Detailed and extensive market segments with regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

CHAPTER 1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

CHAPTER 2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendation
    • 2.2.3. Conclusion
  • 2.3. Regulations

CHAPTER 3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. High Prevalence of Cancer Diseases Globally
    • 3.1.2. Preference of Minimally Invasive Method Over Alternate Invasive Method
    • 3.1.3. Rising Investment and Funding for Liquid Biopsy along with increasing R&D
    • 3.1.4. Collaboration Between Companies and Public Organization
  • 3.2. Restraints
    • 3.2.1. Lack of Awareness in Developing and Underdeveloped Regions
  • 3.3. Opportunities
    • 3.3.1. Technological Advancement in Liquid Biopsy

CHAPTER 4. Market Segmentation

  • 4.1. Global Liquid Biopsy Market by Biomarker Type
    • 4.1.1. Circulating Tumor Cells
    • 4.1.2. Circulating Tumor DNA (ctDNA)
    • 4.1.3. Others (Extracellular Vesicles)
  • 4.2. Global Liquid Biopsy Market by Cancer Type
    • 4.2.1. Lung Cancer
    • 4.2.2. Breast Cancer
    • 4.2.3. Prostate Cancer
    • 4.2.4. Colorectal Cancer
    • 4.2.5. Other Cancers
  • 4.3. Global Liquid Biopsy Market by End-User
    • 4.3.1. Hospitals and Laboratories
    • 4.3.2. Academic and Research Centres

CHAPTER 5. Competitive Landscape

  • 5.1. Key Company Analysis
  • 5.2. Key Strategy Analysis

CHAPTER 6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. RoE
  • 6.3. Asia-Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of The World

CHAPTER 7. Company Profiles

  • 7.1. Biocept Inc.
  • 7.2. Biodesix, Inc.
  • 7.3. Bio-Rad Laboratories Inc.
  • 7.4. CellMax Life
  • 7.5. Circulogene
  • 7.6. Clearbridge Biomedics Pte Ltd.
  • 7.7. Cynvenio Biosystems, Inc.
  • 7.8. Epigenomics AG
  • 7.9. Exosome Diagnostics Inc.
  • 7.10. F. Hoffmann-La Roche AG
  • 7.11. Genomic Health Inc.
  • 7.12. Guardant Health Inc.
  • 7.13. Inivata Ltd.
  • 7.14. Lariat Biosciences, Inc.
  • 7.15. MDxHealth SA
  • 7.16. Menarini-Silicon Biosystems
  • 7.17. Personal Genome Diagnostics Inc.
  • 7.18. QIAGEN NV
  • 7.19. Raindance Technologies, Inc.
  • 7.20. Thermo Fisher Scientific Inc.
  • 7.21. Trovagene, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.